News
JAK2 inhibition could reduce risk of GVHD
Preclinical research suggests that targeting JAK2 can reduce the risk of graft-versus-host disease (GVHD) in transplant recipients. Researchers...
News
Child’s cancer diagnosis can affect mother’s income long-term
A study conducted in Sweden revealed that social benefits can ease financial burdens for parents of children recently diagnosed with cancer....
Article
Antibiotic Overprescribing: Still a Major Concern
We know you know that you aren't supposed to hand out antibiotics like they're candy. And yet, at least 30% of prescribed antibiotics are...
News
Evidence-based care processes decrease mortality in Staphylococcus aureus bacteremia
What are the trends in patient outcome for Staphylococcus aureus bacteremia (SAB)? Does the use of evidence-based care processes decrease...
Opinion
Impostor syndrome
Impostor syndrome is common and often occurs at moments of transition.
Article
Hypopigmented Discoloration on the Thigh
A 39-year-old woman presented with 2 areas of hypopigmented discoloration on the left thigh of 6 months' duration. The hypopigmentation was more...
News
Here comes bimekizumab, the newest IL-17 inhibitor
KAUAI, HAWAII – “If this holds up in phase 3, it’s going to be a new world for our patients and for us, ” said Craig L. Leonardi, MD.
News
Virtual reality–based CBT may improve social participation in psychosis
Researchers found a drop in safety behaviors – such as lack of eye contact – among patients who received the therapy.
News
Expert shares tips for positioning biologics in IBD patient treatment
LAS VEGAS – Edward V. Loftus Jr., MD, chooses biologics for IBD patients based on age, medical history, and extraintestinal manifestations.
News
Enzalutamide shines in nonmetastatic castration-resistant prostate cancer
SAN FRANCISCO - Metastasis-free survival was 36.6 months with enzalutamide and 14.7 months with placebo.